1. Home
  2. STN vs RDY Comparison

STN vs RDY Comparison

Compare STN & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • RDY
  • Stock Information
  • Founded
  • STN 1954
  • RDY 1984
  • Country
  • STN Canada
  • RDY India
  • Employees
  • STN N/A
  • RDY N/A
  • Industry
  • STN Military/Government/Technical
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • STN Consumer Discretionary
  • RDY Health Care
  • Exchange
  • STN Nasdaq
  • RDY Nasdaq
  • Market Cap
  • STN 12.8B
  • RDY 11.6B
  • IPO Year
  • STN N/A
  • RDY N/A
  • Fundamental
  • Price
  • STN $109.40
  • RDY $13.43
  • Analyst Decision
  • STN
  • RDY Strong Buy
  • Analyst Count
  • STN 0
  • RDY 2
  • Target Price
  • STN N/A
  • RDY $16.95
  • AVG Volume (30 Days)
  • STN 139.8K
  • RDY 1.2M
  • Earning Date
  • STN 11-13-2025
  • RDY 10-24-2025
  • Dividend Yield
  • STN 0.57%
  • RDY 0.53%
  • EPS Growth
  • STN 29.73
  • RDY 9.95
  • EPS
  • STN 2.80
  • RDY 0.79
  • Revenue
  • STN $4,511,386,797.00
  • RDY $3,851,623,984.00
  • Revenue This Year
  • STN $12.60
  • RDY $7.33
  • Revenue Next Year
  • STN $10.55
  • RDY $2.00
  • P/E Ratio
  • STN $39.10
  • RDY $17.01
  • Revenue Growth
  • STN 13.47
  • RDY 14.10
  • 52 Week Low
  • STN $73.18
  • RDY $12.26
  • 52 Week High
  • STN $114.52
  • RDY $16.17
  • Technical
  • Relative Strength Index (RSI)
  • STN 44.10
  • RDY 35.68
  • Support Level
  • STN $111.31
  • RDY $13.20
  • Resistance Level
  • STN $114.27
  • RDY $14.94
  • Average True Range (ATR)
  • STN 1.94
  • RDY 0.28
  • MACD
  • STN -0.28
  • RDY -0.13
  • Stochastic Oscillator
  • STN 13.96
  • RDY 15.77

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: